FICOSTERRA
FICOSTERRA is a marine biotechnology company that manufactures plant biostimulants for the optimal agronomic performance of crops.
Ficosterra´s solutions help farmers increase the yield of their crops by means of sustainable and cost-effective biological solutions that ensure better harvests, increase plant resiliency and optimize ROI.
What collaboration are we looking for?
New relationships and commercial agreements
What solutions and opportunities are we offering?
Nutrient Use Efficiency
Water Use Efficiency
Hormonal (organic) active principles
Laminarin and other Polysaccharides extracted from seaweed
Unique Selling Points
• Proprietary technology for extraction phytohormones from marine seaweed.
• Proprietary extraction process for alginates, polysaccharides and microbial inoculants:
– Targeted Microorganisms: Microbial strains have been selected to specifically increase Nutrient Use Efficiency in Nitrogen, Phosphorus, Potassium absorption by roots;
– Synergy Seaweed-Microorganisms: Seaweed has been extracted to provide high content of polysaccharides that amplifies the populations of our specific microbes by 100 times, acting as prebiotics; this reinforced microbial population act as probiotic and allows more organic nutrient availability to roots;
– Targeted Seaweed: To increases plant resiliency to stress and water scarcity.
• Taylor made products adapted to customers’ requirements.
Additional geographies of business operation
Africa, Europe, Latin America
Maturity / funding
Series A
Additional Information
Funding received ($) and name of funders
$3,500,000.00
... of which equity investment
$1,500,000.00
... of which grants
$1,200,000.00
... of which loans & other funding
$800,000.00
Awards received, and brief description of the award(s)
Seal of Excellent, 2022. Topic: organic hormones by means of fluid gas extraction
Expected opening of next investment round
Q2_2025
Expected funding sought from next investment round
investment: 3M€. Pre.Money valuation: 10M€
Expected closing of next investment round
Q4_2025
Intellectual property & regulation
What is the IP status of your innovation(s)?
Two patents under evaluation
What regulatory approvals are you currently seeking, or have already been achieved?
EU biostimulant (EU) 2019/1009 – FCP6 APHIS USDA – microbials
